The mRNA expression of SETD2 in human breast cancer: correlation with clinico-pathological parameters

Abstract

This study demonstrates a compelling trend for SETD2 transcription levels to be lower in cancerous tissues and in patients who developed progressive disease. These findings are consistent with a possible tumour suppressor function of this gene in breast cancer.